Abstract is: Sir Iain Geoffrey Chalmers FRCOG FRCPE FMedSci (born 3 June 1943) is a British health services researcher, one of the founders of the Cochrane Collaboration, and coordinator of the James Lind Initiative, which includes the James Lind Library and James Lind Alliance.
| human | Q5 |
| P1617 | BBC Things ID | 853011b3-ddc4-4cd9-ba0a-722e96d711d3 |
| P11496 | CiNii Research ID | 1140563741675905536 |
| P646 | Freebase ID | /m/0d0yy3 |
| P3885 | History of Modern Biomedicine ID | iain-chalmers |
| P213 | ISNI | 0000000083706383 |
| P244 | Library of Congress authority ID | n85803236 |
| P271 | NACSIS-CAT author ID | DA0381763X |
| P8189 | National Library of Israel J9U ID | 987007328225905171 |
| P5034 | National Library of Korea ID | KAC201815726 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 06770168X |
| P349 | NDL Authority ID | 00820210 |
| P1015 | NORAF ID | 90166217 |
| P1207 | NUKAT ID | n99710691 |
| P3368 | Prabook ID | 2358049 |
| P3430 | SNAC ARK ID | w6rc9s45 |
| P3029 | UK National Archives ID | F254588 |
| P214 | VIAF ID | 278365568 |
| P4789 | Who's Who UK ID | U10548 |
| P10832 | WorldCat Entities ID | E39PBJpDRb6ttq97vGxxCPDjG3 |
| P166 | award received | Knight Bachelor | Q833163 |
| Fellow of the Royal College of Physicians of London | Q26204035 | ||
| Fellow of the Royal College of Physicians of Edinburgh | Q30348773 | ||
| Fellow of the Faculty of Public Health | Q30458765 | ||
| BMJ Lifetime Achievement Award | Q42742375 | ||
| P27 | country of citizenship | United Kingdom | Q145 |
| P734 | family name | Chalmers | Q21484749 |
| Chalmers | Q21484749 | ||
| Chalmers | Q21484749 | ||
| P735 | given name | Iain | Q1655354 |
| Iain | Q1655354 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | physician | Q39631 |
| P21 | sex or gender | male | Q6581097 |
| Q28602707 | A European multi-language initiative to make the general population aware of independent clinical research: the European Communication on Research Awareness Need project |
| Q40657176 | A brief history of research synthesis |
| Q37713273 | A field guide to experts |
| Q34666599 | A new network to promote evidence-based research |
| Q24537212 | A surrealistic mega-analysis of redisorganization theories |
| Q36531799 | A surrealistic mega-analysis of redisorganization theories. |
| Q48068713 | A tapestry of Palestinian life: remembering Samar Alhallaq |
| Q59304279 | Abstracts of the 2nd Clinical Trials Methodology Conference: Methodology Matters, 18-19 November 2013, Edinburgh, UK |
| Q43123715 | Academic medicine: time for reinvention: MRC aims to give NHS evidence from randomised clinical trials |
| Q33961015 | Accumulating research: a systematic account of how cumulative meta-analyses would have provided knowledge, improved health, reduced harm and saved resources |
| Q45715624 | Acknowledging and researching treatment uncertainties in paediatric practice: an ethical imperative |
| Q24564772 | Adding fluoride to water supplies |
| Q55276183 | Addressing uncertainties about the effects of treatments offered to NHS patients: whose responsibility? |
| Q55031245 | Adrian Grant's pioneering use of evidence synthesis in perinatal medicine, 1980-1992. |
| Q50566485 | Alexander Lesassier Hamilton's 1816 report of a controlled trial of bloodletting. |
| Q28816157 | All trials must be registered and the results published |
| Q48069831 | An open letter for the people in Gaza |
| Q51235997 | Are any of the criticisms of the CNEP trial true? |
| Q24536914 | Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group |
| Q37471148 | Assessing authority |
| Q35113528 | Assessing the quality of research |
| Q30911439 | Avoidable waste in the production and reporting of research evidence |
| Q36951378 | Better information systems are needed to help patients and clinicians integrate clinical research within everyday clinical practice |
| Q34658526 | Biased under-reporting of research reflects biased under-submission more than biased editorial rejection |
| Q33265087 | Biased underreporting of research is unethical and should be outlawed |
| Q48632336 | Bill Silverman: a personal appreciation. |
| Q24707976 | Biomedical research: increasing value, reducing waste |
| Q42784367 | Britain's first minister of public health. National centre for public health is needed |
| Q30835721 | Can an educational podcast improve the ability of parents of primary school children to assess the reliability of claims made about the benefits and harms of treatments: study protocol for a randomised controlled trial |
| Q33793659 | Challenges in evaluating surgical innovation |
| Q53569338 | Choosing treatments when the effect of alternatives is uncertain. |
| Q52947841 | Clinical trials in NZ: does anybody know what's going on? |
| Q56689284 | Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting |
| Q38533967 | Commentary for history special issue of Research Synthesis Methods |
| Q48495716 | Commentary: The evolution of methods to assess the effects of treatments, illustrated by the development of treatments for diphtheria, 1825-1918. |
| Q33201544 | Commentary: the 1944 patulin trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council |
| Q63479419 | Consent in emergency care research – Authors' reply |
| Q47867655 | Critical thinking in healthcare and education |
| Q24792307 | Current Controlled Trials: an opportunity to help improve the quality of clinical research |
| Q27009133 | Data sharing among data monitoring committees and responsibilities to patients and science |
| Q56768058 | Dealing with the unknown: reducing the proportion of unvalidated treatments offered to children |
| Q37043648 | Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002 |
| Q56689282 | Discussion Sections in Reports of Controlled Trials Published in General Medical Journals |
| Q34661945 | Discussion sections in reports of controlled trials published in general medical journals |
| Q36006038 | Documenting the evidence: the case of scurvy. |
| Q30851935 | Does the use of the Informed Healthcare Choices (IHC) primary school resources improve the ability of grade-5 children in Uganda to assess the trustworthiness of claims about the effects of treatments: protocol for a cluster-randomised trial |
| Q50634980 | Edmund Hey - a personal appreciation. |
| Q28080302 | Educational interventions to improve people's understanding of key concepts in assessing the effects of health interventions: a systematic review protocol |
| Q53282851 | Educational interventions to improve people's understanding of key concepts in assessing the effects of health interventions: a systematic review. |
| Q45117645 | Effect of consent rituals on mortality in emergency care research |
| Q38679665 | Effects of the Informed Health Choices podcast on the ability of parents of primary school children in Uganda to assess claims about treatment effects: a randomised controlled trial |
| Q38679669 | Effects of the Informed Health Choices primary school intervention on the ability of children in Uganda to assess the reliability of claims about treatment effects: a cluster-randomised controlled trial |
| Q55083556 | Erratum to: Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch. |
| Q41105598 | Establishing a library of resources to help people understand key concepts in assessing treatment claims-The "Critical thinking and Appraisal Resource Library" (CARL) |
| Q43124341 | Ethics review roulette: what can we learn? |
| Q53062486 | Explaining the unbiased creation of treatment comparison groups. |
| Q43122822 | Fair tests of health-care policies and treatments: a request for help from readers |
| Q24187749 | Farewell and thanks to Dave Sackett, Cochrane's first pilot |
| Q31033139 | Fisher and Bradford Hill: theory and pragmatism? |
| Q36412893 | Focus on sharing individual patient data distracts from other ways of improving trial transparency |
| Q58665061 | For ethical, economic and scientific reasons, health-relevant degree theses must be made publicly accessible |
| Q50932566 | From optimism to disillusion about commitment to transparency in the medico-industrial complex. |
| Q33400636 | Gaza--a symptom of an insufficiently acknowledged cause |
| Q42386832 | Government regulation is needed to prevent biased under-reporting of clinical trials |
| Q48444721 | Harry Marks: an appreciation. |
| Q43720204 | Health Research Authority's great leap forward on UK trial registration |
| Q35082894 | How to formulate research recommendations |
| Q48099005 | How to increase value and reduce waste when research priorities are set. |
| Q53151172 | Human rights and professional responsibilities in health care and education. |
| Q33790916 | Incorporating patient preferences into clinical trials. Information about patients' preference must be obtained first |
| Q55059415 | Increasing the Incidence and Influence of Systematic Reviews on Health Policy and Practice. |
| Q28657841 | Increasing value and reducing waste in biomedical research regulation and management |
| Q38595958 | Increasing value and reducing waste in biomedical research: who's listening? |
| Q48250436 | Intentional self-plagiarism |
| Q34663906 | Intervention synthesis: a missing link between a systematic review and practical treatment(s). |
| Q36190919 | Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments? |
| Q50922383 | J Guy Scadding and the move from alternation to randomisation. |
| Q50697160 | Joseph Asbury Bell and the birth of randomized trials. |
| Q48172507 | Key Concepts for Informed Health Choices: a framework for helping people learn how to assess treatment claims and make informed choices |
| Q61811016 | Key Concepts for assessing claims about treatment effects and making well-informed treatment choices |
| Q38858675 | Key concepts that people need to understand to assess claims about treatment effects |
| Q33415745 | Lancet Steering Group on the occupied Palestinian territory |
| Q50060439 | Larger effect sizes in non-randomized studies are associated with higher rates of EMA licensing approval. |
| Q58668211 | Lessons for research ethics committees |
| Q49111073 | Magnesium for preventing and treating eclampsia: time for international action. |
| Q35653223 | Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform |
| Q38850233 | Measuring ability to assess claims about treatment effects: the development of the 'Claim Evaluation Tools'. |
| Q45990274 | Medical journal editors and publication bias. |
| Q42920052 | Medical research: Trial unpredictability yields predictable therapy gains |
| Q53079104 | Mis-investigating alleged research misconduct can cause widespread, unpredictable damage. |
| Q62228692 | Misrepresentation of the National Women's Hospital in Auckland, New Zealand |
| Q24198868 | New treatments compared to established treatments in randomized trials |
| Q24246150 | New treatments compared to established treatments in randomized trials |
| Q43510923 | No surgical innovation without evaluation: the IDEAL recommendations |
| Q42604805 | Open letter to President Obama on hunger strikers in Guantanamo |
| Q30829565 | Open letter: European Medicines Agency should remove barriers to access clinical trial data |
| Q34667712 | PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts |
| Q57775463 | Patients' research priorities get funded |
| Q50900071 | Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch. |
| Q53232196 | Preventing scientific misconduct. |
| Q53375749 | Provision of consent. |
| Q34585164 | Raising the standards of clinical trials and research |
| Q55055406 | Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO. |
| Q57168775 | Reducing harm and maximizing benefit |
| Q56689283 | Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report |
| Q43176617 | Research ethics committees |
| Q61822225 | Research waste is still a scandal—an essay by Paul Glasziou and Iain Chalmers |
| Q53099181 | Research: increasing value, reducing waste - Authors' reply. |
| Q33257636 | Role of systematic reviews in detecting plagiarism: case of Asim Kurjak |
| Q30670520 | Secure use of individual patient data from clinical trials |
| Q24288768 | Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? |
| Q28602835 | Should there be greater use of preprint servers for publishing reports of biomedical science? |
| Q57759889 | Support for UNRWA's survival |
| Q47750932 | Support the opposition to force feeding of hunger strikers in Israel |
| Q35074668 | Survey of claims of no effect in abstracts of Cochrane reviews |
| Q24235248 | Systematic reviews and uncertainties about the effects of treatments |
| Q53015267 | TGN1412 and The Lancet's solicitation of reports of phase I trials. |
| Q55426274 | Tackling treatment uncertainties together: the evolution of the James Lind Initiative, 2003-2013. |
| Q37780029 | Taking healthcare interventions from trial to practice |
| Q43108036 | Testing transparency. Interview by Fiona Fleck |
| Q38467368 | Testing treatments interactive (TTi): helping to equip the public to promote better research for better health care |
| Q24558615 | The James Lind Initiative |
| Q61800602 | The James Lind Initiative: books, websites and databases to promote critical thinking about treatment claims, 2003 to 2018 |
| Q52979162 | The advent of fair treatment allocation schedules in clinical trials during the 19th and early 20th centuries. |
| Q35171400 | The development of fair tests of treatments |
| Q28248849 | The origins, evolution, and future of The Cochrane Database of Systematic Reviews |
| Q39364567 | The quality of reports of medical and public health research from Palestinian institutions: a systematic review |
| Q36178405 | Towards evidence based research |
| Q52919848 | UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition. |
| Q53392860 | Under-reporting of clinical trials is unethical. |
| Q48547512 | Use of research evidence in practice. |
| Q43172971 | Well informed uncertainties about the effects of treatments |
| Q53947900 | What are funders doing to minimise waste in research? |
| Q33233736 | What are the implications of optimism bias in clinical research? |
| Q24673438 | When are randomised trials unnecessary? Picking signal from noise |
| Q33268718 | Why fair tests are needed: a brief history |
| Q46322357 | Why the GMC should set up a central registry of doctors' competing interests |
| Q53980652 | Why we need to know whether prophylactic antibiotics can reduce measles-related morbidity. |
| Q52343265 | [Alessandro Liberati: a personal appreciation]. |
| Q1105202 | Cochrane | founded by | P112 |
| Category:Iain Chalmers | wikimedia | |
| Arabic (ar / Q13955) | لاين شالمرز | wikipedia |
| Egyptian Arabic (arz / Q29919) | لاين شالمرز | wikipedia |
| Iain Chalmers | wikipedia | |
| Iain Chalmers | wikipedia | |
| Iain Chalmers | wikipedia |
Search more.